Insider information
11. September 2023 - 0:00 (CEST)
Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
Read more02. August 2023 - 0:00 (CEST)
Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
Read more24. July 2023 - 0:00 (CEST)